Accuray incorporated ARAY.US AI Analysis
BetaUS StockHealthcare
(No presentation for ARAY)
ARAY Value Score
3
24
15
Excellent Growth
Analysis Conclusion
The stock has received the highest rating for its value, but its dividend score is below 2. If the company starts distributing dividends, it may yield even better investment results.
ARAY Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of ARAY from 2007-02-08 till Now
- -48.55%
- Cumulative Return
- -3.56%
- Annual Return
- 29.00%
- Volatility
- -0.12
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from February, 2007 to June, 2025. (Total Trades: 4)
| ARAY | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | 25% | 47% | 55% |
| Avg Return | -8.6% | 46.6% | 59% |
| Avg Profit | 55.4% | 145% | 131.5% |
| Avg Loss | -29.9% | -40.6% | -31.1% |
| Avg Risk-Reward Ratio | 185.3% | 357.3% | 422.1% |